Kahira Pharmaceuticals posts profit growth in FY 2020/2021
Updated 9/8/2021 11:03:00 AM
ArabFinance: Kahira Pharmaceuticals and Chemical Industries Company (CPCI) reported a net profit after tax of EGP 124.30 million for fiscal year 2020/2021, compared to profits of EGP 109.14 million in FY 2019/2020, according to the company’s financial statement filed to the Egyptian Exchange (EGX).
The company’s operating revenue amounted to EGP 1.06 billion in FY 2020/2021, slightly up from EGP 1.01 billion in FY 2019/2020.
Kahira Pharmaceuticals is an Egypt-based company involved in the manufacture and trade of pharmaceutical products for human and veterinary use.
